We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the medicines.ie website. Find out more

Eli Lilly and Company (Ireland) Limited

Dunderrow, Kinsale, Co. Cork, P17 NY71, Ireland
Telephone: +353 1 661 4377
WWW: http://www.lilly.ie
Medical Information Direct Line: +44 (0)1256 315 000
Patient Information Leaflet last updated on medicines.ie: 2/14/2018
PIL Humulin M3 (Mixture 3), 100IU/ml suspension for injection in cartridge

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 2/14/2018 and displayed until Current
Reasons for adding or updating:
  • Change to section 6 - date of revision
Updated on 3/21/2017 and displayed until 2/14/2018
Reasons for adding or updating:
  • Change to section 3 - dose and frequency
  • Change to section 6 - marketing authorisation number
  • Change to section 6 - date of revision
  • Improved presentation of PIL
Updated on 5/13/2015 and displayed until 3/21/2017
Reasons for adding or updating:
  • Change to date of revision
  • Addition of information on reporting a side effect.
  • Correction of spelling/typing errors
Updated on 6/21/2012 and displayed until 5/13/2015
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
Updated on 4/1/2010 and displayed until 6/21/2012
Reasons for adding or updating:
  • Change of manufacturer
  • Change to date of revision
  • Change due to harmonisation of patient information leaflet
Updated on 2/1/2008 and displayed until 4/1/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to marketing authorisation holder
Updated on 6/25/2007 and displayed until 2/1/2008
Reasons for adding or updating:
  • Change of inactive ingredient
  • Change to improve clarity and readability
  • Change to date of revision
Updated on 6/21/2006 and displayed until 6/25/2007
Reasons for adding or updating:
  • Improved electronic presentation
Updated on 9/14/2004 and displayed until 6/21/2006
Reasons for adding or updating:
  • New PIL for medicines.ie

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
   Insulin human